Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

摘要

Tenofovir is associated with reduced renal function, but it is not clear whether there is a greater decline in renal function when tenofovir is co-administered with a boosted protease inhibitor rather than with a nonnucleoside reverse transcriptase inhibitor (NNRTI).